Cerebrovascular Disorders
1
Pipeline Programs
5
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
2 programs1
Constraint-Induced Movement TherapyPhase 21 trial
Environmental Pollutants and Neurological DisordersN/A1 trial
Active Trials
Innovation PharmaceuticalsMA - Wakefield
1 programImproving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Human BioSciencesConstraint-Induced Movement Therapy
Human BioSciencesEnvironmental Pollutants and Neurological Disorders
Innovation PharmaceuticalsImproving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-
Artery TherapeuticsNo study-specific intervention
Clinical Trials (4)
Total enrollment: 1,993 patients across 4 trials
Treatment for Movement Problems in Elderly Stroke Patients
Start: Dec 199980 patients
Phase 2Completed
Environmental Pollutants and Neurological Disorders
Start: Aug 2025Est. completion: Aug 2027500 patients
N/ARecruiting
NCT04109612Innovation PharmaceuticalsImproving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-
Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-
Start: Jul 2019Est. completion: Jan 2022913 patients
N/ACompleted
International Intracranial Dissection Study
Start: Aug 2016Est. completion: Nov 2027500 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 1,993 patients
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.